Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 151 entries
Sorted by: Best Match Show Resources per page
HTLV infection in HCV-antibody positive patients in Spain.

AIDS research and human retroviruses

Treviño A, Aguilera A, Rodríguez-Iglesias MA, Hernandez A, Benito R, Roc L, Ramos JM, Ortíz de Lejarazu R, Poveda E, Rodríguez C, Del Romero J, Calderon E, García J, Requena S, Soriano V, de Mendoza C.
PMID: 28269998
AIDS Res Hum Retroviruses. 2017 Ocy;33(10):1013-1017. doi: 10.1089/AID.2016.0323. Epub 2017 Mar 07.

Since hepatitis C virus (HCV) and human T-lymphotropic virus (HTLV) share transmission routes, dual infection could be frequent. In Spain, HTLV underdiagnosis is highlighted by the high proportion of patients presenting either with tropical spastic paraparesis (TSP) or adult...

Cite
Treviño A, Aguilera A, Rodríguez-Iglesias MA, et al. HTLV infection in HCV-antibody positive patients in Spain. AIDS Res Hum Retroviruses. 2017;33(10):1013-1017doi: 10.1089/AID.2016.0323.
Treviño, A., Aguilera, A., Rodríguez-Iglesias, M. A., Hernandez, A., Benito, R., Roc, L., Ramos, J. M., Ortíz de Lejarazu, R., Poveda, E., Rodríguez, C., Del Romero, J., Calderon, E., García, J., Requena, S., Soriano, V., & de Mendoza, C. (2017). HTLV infection in HCV-antibody positive patients in Spain. AIDS research and human retroviruses, 33(10), 1013-1017. https://doi.org/10.1089/AID.2016.0323
Treviño, Ana, et al. "HTLV infection in HCV-antibody positive patients in Spain." AIDS research and human retroviruses vol. 33,10 (2017): 1013-1017. doi: https://doi.org/10.1089/AID.2016.0323
Treviño A, Aguilera A, Rodríguez-Iglesias MA, Hernandez A, Benito R, Roc L, Ramos JM, Ortíz de Lejarazu R, Poveda E, Rodríguez C, Del Romero J, Calderon E, García J, Requena S, Soriano V, de Mendoza C. HTLV infection in HCV-antibody positive patients in Spain. AIDS Res Hum Retroviruses. 2017 Ocy;33(10):1013-1017. doi: 10.1089/AID.2016.0323. Epub 2017 Mar 07. PMID: 28269998.
Copy Download .nbib Format: NLM
HIV-Positive Individuals on Antiretroviral Therapy and with Viral Load Suppressed in 12 Infectious Diseases Clinics in Italy: Successes and Disparities in the HIV Continuum of Care.

AIDS research and human retroviruses

Raimondo M, Camoni L, Suligoi B, Pezzotti P.
PMID: 28135809
AIDS Res Hum Retroviruses. 2017 Jun;33(6):575-582. doi: 10.1089/AID.2016.0256. Epub 2017 Mar 06.

The HIV care continuum is a tool that describes the quality of HIV care for people living with HIV and assesses the extent to which the goal of viral suppression has been achieved. In 2014, we conducted a retrospective...

Cite
Raimondo M, Camoni L, Suligoi B, et al. HIV-Positive Individuals on Antiretroviral Therapy and with Viral Load Suppressed in 12 Infectious Diseases Clinics in Italy: Successes and Disparities in the HIV Continuum of Care. AIDS Res Hum Retroviruses. 2017;33(6):575-582doi: 10.1089/AID.2016.0256.
Raimondo, M., Camoni, L., Suligoi, B., Pezzotti, P. (2017). HIV-Positive Individuals on Antiretroviral Therapy and with Viral Load Suppressed in 12 Infectious Diseases Clinics in Italy: Successes and Disparities in the HIV Continuum of Care. AIDS research and human retroviruses, 33(6), 575-582. https://doi.org/10.1089/AID.2016.0256
Raimondo, Mariangela, et al. "HIV-Positive Individuals on Antiretroviral Therapy and with Viral Load Suppressed in 12 Infectious Diseases Clinics in Italy: Successes and Disparities in the HIV Continuum of Care." AIDS research and human retroviruses vol. 33,6 (2017): 575-582. doi: https://doi.org/10.1089/AID.2016.0256
Raimondo M, Camoni L, Suligoi B, Pezzotti P. HIV-Positive Individuals on Antiretroviral Therapy and with Viral Load Suppressed in 12 Infectious Diseases Clinics in Italy: Successes and Disparities in the HIV Continuum of Care. AIDS Res Hum Retroviruses. 2017 Jun;33(6):575-582. doi: 10.1089/AID.2016.0256. Epub 2017 Mar 06. PMID: 28135809.
Copy Download .nbib Format: NLM
Time to Engage Young People in HIV Cure Research.

AIDS research and human retroviruses

Saberi P, Campbell CK, Venegas M, Dubé K.
PMID: 33677996
AIDS Res Hum Retroviruses. 2022 Jan;38(1):2-4. doi: 10.1089/AID.2020.0268. Epub 2021 Apr 01.

Antiretroviral treatments successfully suppress and control HIV but cannot eliminate the virus. In recent years, much research has gone into developing a cure for HIV. This research comes with significant risks and limited clinical benefits to study participants. Little...

Cite
Saberi P, Campbell CK, Venegas M, et al. Time to Engage Young People in HIV Cure Research. AIDS Res Hum Retroviruses. 2021;38(1):2-4doi: 10.1089/AID.2020.0268.
Saberi, P., Campbell, C. K., Venegas, M., & Dubé, K. (2022). Time to Engage Young People in HIV Cure Research. AIDS research and human retroviruses, 38(1), 2-4. https://doi.org/10.1089/AID.2020.0268
Saberi, Parya, et al. "Time to Engage Young People in HIV Cure Research." AIDS research and human retroviruses vol. 38,1 (2022): 2-4. doi: https://doi.org/10.1089/AID.2020.0268
Saberi P, Campbell CK, Venegas M, Dubé K. Time to Engage Young People in HIV Cure Research. AIDS Res Hum Retroviruses. 2022 Jan;38(1):2-4. doi: 10.1089/AID.2020.0268. Epub 2021 Apr 01. PMID: 33677996.
Copy Download .nbib Format: NLM
Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda.

AIDS research and human retroviruses

Galiwango RM, Ssuuna C, Kaleebu P, Kigozi G, Kagaayi J, Nakigozi G, Reynolds SJ, Lutalo T, Kankaka EN, Wasswa JB, Kalibbala SN, Kigozi AN, Watera C, Ejang J, Ndyanabo A, Anok AJ, Ssemwanga D, Kibengo FM, Quinn TC, Grabowski M, Chang LW, Wawer M, Gray R, Laeyendecker O, Serwadda D.
PMID: 33499732
AIDS Res Hum Retroviruses. 2021 Feb 25; doi: 10.1089/AID.2020.0279. Epub 2021 Feb 25.

Point of care rapid recency testing for HIV-1 may be a cost-effective tool to identify recently infected individuals for incidence estimation, and focused HIV prevention through intensified contact tracing. We validated the Asante™ HIV-1 rapid recency

Cite
Galiwango RM, Ssuuna C, Kaleebu P, et al. Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda. AIDS Res Hum Retroviruses. 2021;doi: 10.1089/AID.2020.0279.
Galiwango, R. M., Ssuuna, C., Kaleebu, P., Kigozi, G., Kagaayi, J., Nakigozi, G., Reynolds, S. J., Lutalo, T., Kankaka, E. N., Wasswa, J. B., Kalibbala, S. N., Kigozi, A. N., Watera, C., Ejang, J., Ndyanabo, A., Anok, A. J., Ssemwanga, D., Kibengo, F. M., Quinn, T. C., Grabowski, M., Chang, L. W., Wawer, M., Gray, R., Laeyendecker, O., & Serwadda, D. (2021). Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda. AIDS research and human retroviruses, . https://doi.org/10.1089/AID.2020.0279
Galiwango, Ronald Moses, et al. "Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda." AIDS research and human retroviruses vol. (2021). doi: https://doi.org/10.1089/AID.2020.0279
Galiwango RM, Ssuuna C, Kaleebu P, Kigozi G, Kagaayi J, Nakigozi G, Reynolds SJ, Lutalo T, Kankaka EN, Wasswa JB, Kalibbala SN, Kigozi AN, Watera C, Ejang J, Ndyanabo A, Anok AJ, Ssemwanga D, Kibengo FM, Quinn TC, Grabowski M, Chang LW, Wawer M, Gray R, Laeyendecker O, Serwadda D. Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda. AIDS Res Hum Retroviruses. 2021 Feb 25; doi: 10.1089/AID.2020.0279. Epub 2021 Feb 25. PMID: 33499732.
Copy Download .nbib Format: NLM
Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression.

AIDS research and human retroviruses

Hariyanto TI, Putri C, Frinka P, Louisa J, Lugito NPH, Kurniawan A.
PMID: 33499744
AIDS Res Hum Retroviruses. 2021 Jan 27; doi: 10.1089/AID.2020.0307. Epub 2021 Jan 27.

AIDS Research and Human Retroviruses officially retracts the Instant Online/Just Accepted version of the article entitled, "Human Immunodeficiency Virus (HIV) and Outcomes from Coronavirus Disease 2019 (COVID-19) Pneumonia: A Meta-Analysis and Meta-Regression" (epub 27 Jan 2021; doi.org/10.1089/AID.2020.0307). A technical...

Cite
Hariyanto TI, Putri C, Frinka P, et al. Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression. AIDS Res Hum Retroviruses. 2021;doi: 10.1089/AID.2020.0307.
Hariyanto, T. I., Putri, C., Frinka, P., Louisa, J., Lugito, N. P. H., & Kurniawan, A. (2021). Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression. AIDS research and human retroviruses, . https://doi.org/10.1089/AID.2020.0307
Hariyanto, Timotius Ivan, et al. "Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression." AIDS research and human retroviruses vol. (2021). doi: https://doi.org/10.1089/AID.2020.0307
Hariyanto TI, Putri C, Frinka P, Louisa J, Lugito NPH, Kurniawan A. Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression. AIDS Res Hum Retroviruses. 2021 Jan 27; doi: 10.1089/AID.2020.0307. Epub 2021 Jan 27. PMID: 33499744.
Copy Download .nbib Format: NLM
Dyspnea and Pulmonary Function Among Participants in the Multicenter AIDS Cohort Study Using Protease Inhibitors: A Cross-Sectional Study.

AIDS research and human retroviruses

Terry C, Mehta CC, Holloway J, Sheth AN, Ofotokun I, Abraham A, Kunisaki KM, Witt M, McCormack MC, Morris A, Drummond MB, Jensen R, Stosor V, Macatangay BJC, Cribbs SK.
PMID: 34969258
AIDS Res Hum Retroviruses. 2021 Dec 30; doi: 10.1089/AID.2021.0082. Epub 2021 Dec 30.

OBJECTIVE: People living with HIV (PLWH) have a higher prevalence of respiratory symptoms than people without HIV. Antiretroviral therapy (ART) has been associated with worsened airflow limitation. This study assessed respiratory health impairment among PLWH and its association with...

Cite
Terry C, Mehta CC, Holloway J, et al. Dyspnea and Pulmonary Function Among Participants in the Multicenter AIDS Cohort Study Using Protease Inhibitors: A Cross-Sectional Study. AIDS Res Hum Retroviruses. 2021;doi: 10.1089/AID.2021.0082.
Terry, C., Mehta, C. C., Holloway, J., Sheth, A. N., Ofotokun, I., Abraham, A., Kunisaki, K. M., Witt, M., McCormack, M. C., Morris, A., Drummond, M. B., Jensen, R., Stosor, V., Macatangay, B. J. C., & Cribbs, S. K. (2021). Dyspnea and Pulmonary Function Among Participants in the Multicenter AIDS Cohort Study Using Protease Inhibitors: A Cross-Sectional Study. AIDS research and human retroviruses, . https://doi.org/10.1089/AID.2021.0082
Terry, Charles, et al. "Dyspnea and Pulmonary Function Among Participants in the Multicenter AIDS Cohort Study Using Protease Inhibitors: A Cross-Sectional Study." AIDS research and human retroviruses vol. (2021). doi: https://doi.org/10.1089/AID.2021.0082
Terry C, Mehta CC, Holloway J, Sheth AN, Ofotokun I, Abraham A, Kunisaki KM, Witt M, McCormack MC, Morris A, Drummond MB, Jensen R, Stosor V, Macatangay BJC, Cribbs SK. Dyspnea and Pulmonary Function Among Participants in the Multicenter AIDS Cohort Study Using Protease Inhibitors: A Cross-Sectional Study. AIDS Res Hum Retroviruses. 2021 Dec 30; doi: 10.1089/AID.2021.0082. Epub 2021 Dec 30. PMID: 34969258.
Copy Download .nbib Format: NLM
[No title available]

AIDS research and human retroviruses

[No authors listed]
PMID: 34081872
AIDS Res Hum Retroviruses. 2021 Jun;37(6):503. doi: 10.1089/aid.2020.0307.retract. Epub 2021 May 31.

No abstract available.

Cite
. AIDS Res Hum Retroviruses. 2021;37(6):503doi: 10.1089/aid.2020.0307.retract.
(2021). . AIDS research and human retroviruses, 37(6), 503. https://doi.org/10.1089/aid.2020.0307.retract
"." AIDS research and human retroviruses vol. 37,6 (2021): 503. doi: https://doi.org/10.1089/aid.2020.0307.retract
. AIDS Res Hum Retroviruses. 2021 Jun;37(6):503. doi: 10.1089/aid.2020.0307.retract. Epub 2021 May 31. PMID: 34081872.
Copy Download .nbib Format: NLM
[No title available]

AIDS research and human retroviruses

Reeves RK, Ndhlovu L.
PMID: 34936497
AIDS Res Hum Retroviruses. 2022 Jan;38(1):1. doi: 10.1089/aid.2021.29001.cfp. Epub 2021 Dec 21.

No abstract available.

Cite
Reeves RK, Ndhlovu L. . AIDS Res Hum Retroviruses. 2021;38(1):1doi: 10.1089/aid.2021.29001.cfp.
Reeves, R. K., & Ndhlovu, L. (2022). . AIDS research and human retroviruses, 38(1), 1. https://doi.org/10.1089/aid.2021.29001.cfp
Reeves, R Keith, and Ndhlovu, Lishomwa. "." AIDS research and human retroviruses vol. 38,1 (2022): 1. doi: https://doi.org/10.1089/aid.2021.29001.cfp
Reeves RK, Ndhlovu L. . AIDS Res Hum Retroviruses. 2022 Jan;38(1):1. doi: 10.1089/aid.2021.29001.cfp. Epub 2021 Dec 21. PMID: 34936497.
Copy Download .nbib Format: NLM
Nucleotide Sequence of HIV-1-Positive Specimen Reference Panel for Evaluation of HIV .

AIDS research and human retroviruses

Kusagawa S, Tatsumi M, Sakamoto-Umeki Y, Takekawa N, Matsubayashi K, Ishimaru K, Kawana-Tachikawa A.
PMID: 34652965
AIDS Res Hum Retroviruses. 2021 Dec;37(12):994-997. doi: 10.1089/AID.2021.0160. Epub 2021 Nov 09.

HIV-1 subtype/circulating recombinant form (CRF) distribution of HIV-1-positive specimens for evaluating HIV

Cite
Kusagawa S, Tatsumi M, Sakamoto-Umeki Y, et al. Nucleotide Sequence of HIV-1-Positive Specimen Reference Panel for Evaluation of HIV . AIDS Res Hum Retroviruses. 2021;37(12):994-997doi: 10.1089/AID.2021.0160.
Kusagawa, S., Tatsumi, M., Sakamoto-Umeki, Y., Takekawa, N., Matsubayashi, K., Ishimaru, K., & Kawana-Tachikawa, A. (2021). Nucleotide Sequence of HIV-1-Positive Specimen Reference Panel for Evaluation of HIV . AIDS research and human retroviruses, 37(12), 994-997. https://doi.org/10.1089/AID.2021.0160
Kusagawa, Shigeru, et al. "Nucleotide Sequence of HIV-1-Positive Specimen Reference Panel for Evaluation of HIV ." AIDS research and human retroviruses vol. 37,12 (2021): 994-997. doi: https://doi.org/10.1089/AID.2021.0160
Kusagawa S, Tatsumi M, Sakamoto-Umeki Y, Takekawa N, Matsubayashi K, Ishimaru K, Kawana-Tachikawa A. Nucleotide Sequence of HIV-1-Positive Specimen Reference Panel for Evaluation of HIV . AIDS Res Hum Retroviruses. 2021 Dec;37(12):994-997. doi: 10.1089/AID.2021.0160. Epub 2021 Nov 09. PMID: 34652965.
Copy Download .nbib Format: NLM
Genetic Characterization of a Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) Identified in Yan'an City, China.

AIDS research and human retroviruses

Cheng SW, Chen YP, Qi F, Gao R, Ma KL, Yang P, Xie YN, Gao LL, Chen X, Zhou YH.
PMID: 33757290
AIDS Res Hum Retroviruses. 2021 Dec;37(12):973-977. doi: 10.1089/AID.2021.0058. Epub 2021 Apr 30.

Owing to co-epidemic of CRF01_AE and CRF07_BC in China, increasing numbers of the second-generation recombinants between them have been identified especially among sexual population. In this study, we identified a unique CRF01_AE/CRF07_BC recombinants from a male HIV-1 positive individual...

Cite
Cheng SW, Chen YP, Qi F, et al. Genetic Characterization of a Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) Identified in Yan'an City, China. AIDS Res Hum Retroviruses. 2021;37(12):973-977doi: 10.1089/AID.2021.0058.
Cheng, S. W., Chen, Y. P., Qi, F., Gao, R., Ma, K. L., Yang, P., Xie, Y. N., Gao, L. L., Chen, X., & Zhou, Y. H. (2021). Genetic Characterization of a Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) Identified in Yan'an City, China. AIDS research and human retroviruses, 37(12), 973-977. https://doi.org/10.1089/AID.2021.0058
Cheng, Si-Wei, et al. "Genetic Characterization of a Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) Identified in Yan'an City, China." AIDS research and human retroviruses vol. 37,12 (2021): 973-977. doi: https://doi.org/10.1089/AID.2021.0058
Cheng SW, Chen YP, Qi F, Gao R, Ma KL, Yang P, Xie YN, Gao LL, Chen X, Zhou YH. Genetic Characterization of a Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) Identified in Yan'an City, China. AIDS Res Hum Retroviruses. 2021 Dec;37(12):973-977. doi: 10.1089/AID.2021.0058. Epub 2021 Apr 30. PMID: 33757290.
Copy Download .nbib Format: NLM
Enhancement of HIV Type 1 Antigen-Specific CD4+ T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen.

AIDS research and human retroviruses

Maino VC, Suni MA, Wormsley SB, Carlo DJ, Wallace MR, Moss RB.
PMID: 11153091
AIDS Res Hum Retroviruses. 2000 Dec;16(18):2065-2066. doi: 10.1089/088922200750054819.

No abstract available.

Cite
Maino VC, Suni MA, Wormsley SB, et al. Enhancement of HIV Type 1 Antigen-Specific CD4+ T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen. AIDS Res Hum Retroviruses. 2000;16(18):2065-2066doi: 10.1089/088922200750054819.
Maino, V. C., Suni, M. A., Wormsley, S. B., Carlo, D. J., Wallace, M. R., & Moss, R. B. (2000). Enhancement of HIV Type 1 Antigen-Specific CD4+ T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen. AIDS research and human retroviruses, 16(18), 2065-2066. https://doi.org/10.1089/088922200750054819
Maino, et al. "Enhancement of HIV Type 1 Antigen-Specific CD4+ T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen." AIDS research and human retroviruses vol. 16,18 (2000): 2065-2066. doi: https://doi.org/10.1089/088922200750054819
Maino VC, Suni MA, Wormsley SB, Carlo DJ, Wallace MR, Moss RB. Enhancement of HIV Type 1 Antigen-Specific CD4+ T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen. AIDS Res Hum Retroviruses. 2000 Dec;16(18):2065-2066. doi: 10.1089/088922200750054819. PMID: 11153091.
Copy Download .nbib Format: NLM
HIV-1 Drug Resistance Among Treatment-Naive Transgenders from India.

AIDS research and human retroviruses

Kurle SN, Kandaswami S, Gadhe S, Patil A, Sarkar R, Mehta S, Gangakhedkar R, Arumugam V, Chawla U.
PMID: 34652967
AIDS Res Hum Retroviruses. 2021 Nov 19; doi: 10.1089/AID.2021.0157. Epub 2021 Nov 19.

Transgenders (TGs) are highly affected by HIV with high prevalence of 3.14% in India. Since 2017, targeted preventive efforts have been initiated by the government and HIV-infected TGs are being provided the antiretroviral (ART) treatment. Information on the primary...

Cite
Kurle SN, Kandaswami S, Gadhe S, et al. HIV-1 Drug Resistance Among Treatment-Naive Transgenders from India. AIDS Res Hum Retroviruses. 2021;doi: 10.1089/AID.2021.0157.
Kurle, S. N., Kandaswami, S., Gadhe, S., Patil, A., Sarkar, R., Mehta, S., Gangakhedkar, R., Arumugam, V., & Chawla, U. (2021). HIV-1 Drug Resistance Among Treatment-Naive Transgenders from India. AIDS research and human retroviruses, . https://doi.org/10.1089/AID.2021.0157
Kurle, Swarali N, et al. "HIV-1 Drug Resistance Among Treatment-Naive Transgenders from India." AIDS research and human retroviruses vol. (2021). doi: https://doi.org/10.1089/AID.2021.0157
Kurle SN, Kandaswami S, Gadhe S, Patil A, Sarkar R, Mehta S, Gangakhedkar R, Arumugam V, Chawla U. HIV-1 Drug Resistance Among Treatment-Naive Transgenders from India. AIDS Res Hum Retroviruses. 2021 Nov 19; doi: 10.1089/AID.2021.0157. Epub 2021 Nov 19. PMID: 34652967.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 151 entries